Hypersensitivity to DNA cross-linking agents associated with up- regulation of glucose-regulated stress protein GRP781

Cancer Research

Volumn 57, Issue 22, 1997, Pages 5112-5116

  Chatterjee, Satadal ^a   Hirota, Haruyo ^a   Belfi, Charles A ^a   Berger, Sosamma J ^a   Berger, Nathan A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINONICOTINAMIDE; AMSACRINE; CARMUSTINE; CISPLATIN; DEOXYGLUCOSE; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; HEAT SHOCK PROTEIN; MELPHALAN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHO CELL; CLONOGENIC ASSAY; CYTOTOXICITY; DNA CROSS LINKING; DNA REPAIR; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

6-AMINONICOTINAMIDE; ANIMALS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; CARRIER PROTEINS; CELL LINE; CISPLATIN; CRICETINAE; DEOXYGLUCOSE; DNA REPAIR; DNA, NEOPLASM; HEAT-SHOCK PROTEINS; MELPHALAN; MOLECULAR CHAPERONES; TERATOGENS; UP-REGULATION;

EID: 0030663711     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chatterjee, S., Petzold, S. J., Berger, S. J., and Berger, N. A. Strategy for selection of cell variants deficient in poly(ADP-ribose) polymerase. Exp. Cell Res., 172: 245-257, 1987.
2. Chatterjee, S., Hirschler, N. V., Petzold, S. J., Berger, S. J., and Berger, N. A. Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availability. Exp. Cell Res., 184: 1-15. 1989.
3. Chatterjee, S., Cheng, M-F., Trivedi, D., Petzold, S. J., and Berger, N. A. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun., 1: 389-394, 1990.
4. Chatterjee, S., Cheng, M-F., and Berger, N. A. Hypersensitivity to clinically useful alkylating agents and radiations in poly(ADP-ribose) polymerase-deficient cell lines. Cancer Commun., 2: 401-407, 1990.
5. Chatterjee, S., Cheng, M-F., Berger, S. J., and Berger, N. A. Alkylating agent hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun., 3: 71-75, 1991.
6. Chatterjee, S., Trivedi, D., Petzold, S. J., and Berger, N. A. Mechanism of epipodophyllotoxin induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines. Cancer Res., 50: 2713-2718, 1990.
7. +-deficient V79 cell lines and its relation to resistance to topoisomerase II inhibitor etoposide. Cancer Res., 54: 4405-4411, 1994.
8. Chatterjee, S., Cheng, M-F., Berger, R. B., Berger, S. J., and Berger, N. A. Effect of inhibitors of poly(ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide. Cancer Res., 55: 868-873, 1995.
9. Shen, J., Hughes, C., Chao, C., Cai, J., Bartels, C., Gressner, T., and Subjeck, J. Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc. Natl. Acad. Sci. USA, 84: 3278-3282, 1987.
10. Hughes, C. S., Shen, J. W., and Subjeck, J. R. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res., 49: 4452-4454, 1989.
11. Lee, A. S. Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biochem. Sci., 12: 20-23, 1987.
12. Bole, D. G., Hendershot, L. M., and Kearney, J. F. Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J. Cell Biol., 102: 1558-1566, 1986.
13. Dorner, A. J., Bole, D. G., and Kaufman, R. J. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J. Cell Biol., 105: 2665-2674, 1987.
14. Kassenbrock, C. K., Garcia, P. D., Walter, P, and Kelly, R. B. Heavy chain binding protein recognizes aberrant polypeptides translocated in vitro. Nature (Lond.), 333: 90-93, 1988.
15. Hass, I. G., and Wabl, M. Immunoglobulin heavy chain binding protein. Nature (Lond.), 306: 387-389, 1983.
16. Hendershot, L., Bole, D., Kohler, G., and Kearney, J. F. Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain binding protein. J. Cell Biol., 104: 761-767, 1987.
17. Flynn, G. C., Chappell, T. G., and Rothman, J. E. Peptide binding and release by proteins implicated as catalysts of protein assembly. Science (Washington DC), 245: 385-390, 1989.
18. Gething, M. J., and Sambrook, J. Protein folding in the cell. Nature (Lond.), 355: 33-45, 1992.
19. Braakman, I., Helenius, J., and Helenius, A. Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum. Nature (Lond.), 355: 260-262, 1992.
20. Spiridonidis, C. A., Chatterjee, S., Petzold, S. J., and Berger, N. A. Topoisomerase II-dependent, and -independent mechanisms of etoposide resistance in Chinese Hamster cell lines. Cancer Res., 49: 644-650, 1989.
21. Hashimoto, H., Chatterjee, S., and Berger, N. A. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression. Cancer Res., 55: 4029-4035, 1995.
22. Cheng, M-F., Chatterjee, S., and Berger, N. A. Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens. Oncol. Res., 6: 269-279, 1994.
23. Kohn, K. W., Ewig, R. A. G., Erickson, L. C., and Zwelling, L. A. Measurements of strand breaks and cross-links by alkaline elution. In: E. C. Friedberg and P. C. Hanawalt (eds.). DNA Repair: A Laboratory Manual of Research Procedures. Vol. 1B, pp. 379-401. New York: Marcel Dekker, Inc., 1981.
24. Bradford, M. A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
25. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
26. Towbin, H., Staehlin, T., and Gordon, J. Electronic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
27. Chatterjee, S., Hirota, H., Hashimoto, S., Berger, S. J., and Berger, N. A. Hypersensitivity to DNA cross-linking agents associated with upregulation of glucose regulated stress protein GRP78. Proc. Am. Assoc. Cancer Res., 37: 2557, 1996.
28. Pratt, W. B., Ruddon, R. W., Ensminger, W. D., and Maybaum, J. Covalent DNA binding drugs: nitrogen mustards, aziridines, alkane sulfonates, nitrosoureas, platinum compounds, and monoalkylating agents. In: The Anticancer Drugs, pp. 108-154. New York: Oxford University Press, 1994.
29. 6-Alkylguanine-DNA alkyltransferase: a target for the modulation of drug resistance. In: G. Fisher and B. I. Sikic (eds.), Drug Resistance in Clinical Oncology and Hematology, Vol. 9, pp. 431-450. Philadelphia: W. B. Saunders Co., 1995.
30. Brennand, J., and Margison, G. P. Reduction of toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene. Proc. Natl. Acad. Sci. USA, 83: 6292-6296, 1986.
31. 6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents. Carcinogenesis (Lond.), 9: 45-49, 1988.
32. Berger, N. A., Catino, D. M., and Vietti, T. J. Synergistic antileukemic effect of 6-aminonicotinamide and 1,3-bis(2-chlotoethyl)-1-nitrosourea on L1210 cells in vitro and in vivo. Cancer Res., 42: 4382-4386, 1982.